Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Unexpected Lymphatic Drainage of the Treated Breast.

Raghoo R, Pereira Arias-Bouda LM, Valdés Olmos RA.

Clin Nucl Med. 2019 Jul 12. doi: 10.1097/RLU.0000000000002705. [Epub ahead of print]

PMID:
31306188
2.

Effect of sitagliptin on energy metabolism and brown adipose tissue in overweight individuals with prediabetes: a randomised placebo-controlled trial.

Nahon KJ, Doornink F, Straat ME, Botani K, Martinez-Tellez B, Abreu-Vieira G, van Klinken JB, Voortman GJ, Friesema ECH, Ruiz JR, van Velden FHP, de Geus-Oei LF, Smit F, Pereira Arias-Bouda LM, Berbée JFP, Jazet IM, Boon MR, Rensen PCN.

Diabetologia. 2018 Nov;61(11):2386-2397. doi: 10.1007/s00125-018-4716-x. Epub 2018 Aug 25.

3.

Radiomics in vulvar cancer: first clinical experience using 18F-FDG PET/CT images.

Collarino A, Garganese G, Fragomeni SM, Pereira Arias-Bouda LM, Ieria FP, Boellaard R, Rufini V, de Geus-Oei LF, Scambia G, Valdés Olmos RA, Giordano A, Grootjans W, van Velden FHP.

J Nucl Med. 2018 Jul 20. pii: jnumed.118.215889. doi: 10.2967/jnumed.118.215889. [Epub ahead of print]

4.

The impact of using BARCIST 1.0 criteria on quantification of BAT volume and activity in three independent cohorts of adults.

Martinez-Tellez B, Nahon KJ, Sanchez-Delgado G, Abreu-Vieira G, Llamas-Elvira JM, van Velden FHP, Pereira Arias-Bouda LM, Rensen PCN, Boon MR, Ruiz JR.

Sci Rep. 2018 Jun 4;8(1):8567. doi: 10.1038/s41598-018-26878-4.

5.

Experimental validation of absolute SPECT/CT quantification for response monitoring in breast cancer.

Collarino A, Pereira Arias-Bouda LM, Valdés Olmos RA, van der Tol P, Dibbets-Schneider P, de Geus-Oei LF, van Velden FHP.

Med Phys. 2018 May;45(5):2143-2153. doi: 10.1002/mp.12880. Epub 2018 Apr 10.

PMID:
29572848
6.

The clinical impact of molecular breast imaging in women with proven invasive breast cancer scheduled for breast-conserving surgery.

Collarino A, Valdés Olmos RA, van Berkel LGAJ, Neijenhuis PA, Wijers LMH, Smit F, de Geus-Oei LF, Pereira Arias-Bouda LM.

Breast Cancer Res Treat. 2018 Jun;169(3):513-522. doi: 10.1007/s10549-018-4706-1. Epub 2018 Feb 13.

7.

Is Technetium-99m Sestamibi Imaging Able to Predict Pathologic Nonresponse to Neoadjuvant Chemotherapy in Breast Cancer? A Meta-analysis Evaluating Current Use and Shortcomings.

Collarino A, de Koster EJ, Valdés Olmos RA, de Geus-Oei LF, Pereira Arias-Bouda LM.

Clin Breast Cancer. 2018 Feb;18(1):9-18. doi: 10.1016/j.clbc.2017.06.008. Epub 2017 Jun 29.

PMID:
28728876
8.

Methodological aspects of 99mTc-sestamibi guided biopsy in breast cancer.

Collarino A, Valdés Olmos RA, van der Hoeven AF, Pereira Arias-Bouda LM.

Clin Transl Imaging. 2016;4(5):367-376. Epub 2016 Jul 16. Review.

9.

[Breast-specific gamma imaging in breast cancer].

van Loevezijn AA, van Breda Vriesman AC, Neijenhuis PA, Pereira Arias-Bouda LM.

Ned Tijdschr Geneeskd. 2016;160:A9610. Dutch.

PMID:
26786798
10.

Large-vessel vasculitis: interobserver agreement and diagnostic accuracy of 18F-FDG-PET/CT.

Lensen KD, Comans EF, Voskuyl AE, van der Laken CJ, Brouwer E, Zwijnenburg AT, Pereira Arias-Bouda LM, Glaudemans AW, Slart RH, Smulders YM.

Biomed Res Int. 2015;2015:914692. doi: 10.1155/2015/914692. Epub 2015 Jan 28.

11.

Enzyme-linked immunosorbent assays using immune complexes for the diagnosis of tuberculosis.

Pereira Arias-Bouda LM, Kuijper S, van Deutekom H, van Gijlswijk R, Pekel I, Jansen HM, Kolk AH.

J Immunol Methods. 2003 Dec;283(1-2):115-24.

PMID:
14659904
12.

Development of antigen detection assay for diagnosis of tuberculosis using sputum samples.

Pereira Arias-Bouda LM, Nguyen LN, Ho LM, Kuijper S, Jansen HM, Kolk AH.

J Clin Microbiol. 2000 Jun;38(6):2278-83.

Supplemental Content

Loading ...
Support Center